Microbiology in Human Health and Disease
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section will focus on microbiology in human health and diseases, including infectious diseases, the interaction between pathogenic microorganisms and hosts, bacteriology, mycology, virology and parasitology.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- The Gut Microbiome in Early Life and Beyond: Implications for Health and Disease (Deadline: 30 September 2026)
- Targeting Bacterial and Host Metabolic Enzymes to Overcome Antibiotic Resistance (Deadline: 30 September 2026)
- Mycobacterial Infections: Insights into Pathogenesis, Diagnosis, and Treatment (Deadline: 31 October 2026)
- Emerging Trends in Dental Caries: Insights into Etiology, Risk Factors, and Treatment Strategies (2nd Edition) (Deadline: 31 October 2026)
- From Gut to Vascular Health: The Role of Probiotics, Polyphenols, and Diet in Neuroinflammation and Cardiovascular Dysfunction (Deadline: 31 October 2026)
- Drug-Resistant Bacterial Infections and Alternative Therapies—2nd Edition (Deadline: 31 December 2026)
- Emerging Insights into HIV: Second Edition (Deadline: 31 December 2026)
- Current Perspectives on Human Papillomavirus (HPV)—Second Edition (Deadline: 31 December 2026)
- Microbiomes in Human Health and Diseases: Current Status and Future Prospects (Deadline: 31 December 2026)
- Infectious Diseases: Prevention, Diagnosis, and Treatment Under Antimicrobial Resistance Global Urgency (Deadline: 31 January 2027)
- Host–Pathogen Interactions, Immune Modulation, and Translational Therapeutics (Deadline: 31 January 2027)
- Gut Microbiota and Human Health: Implications for Disease Prevention and Therapy (Deadline: 28 February 2027)
- Human Papillomavirus: Infection Mechanisms and Oncogenic Potential (Deadline: 28 February 2027)
- Next-Generation Approaches in Clinical Antiviral Therapy: From Bench to Bedside (Deadline: 31 March 2027)
- Viral Hepatitis: From Pathophysiology to Therapeutic Approaches (Deadline: 31 March 2027)
- Precision Microbiome Modulation for Metabolic and Inflammatory Diseases (Deadline: 31 March 2027)
